Drugs Made In America Acquisition (DMAAR) Consolidated Net Income (2025)
Drugs Made In America Acquisition (DMAAR) reported Consolidated Net Income of $212958.0 for Q4 2025, down 90.25% quarter-over-quarter from $2.2 million in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Consolidated Net Income (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Consolidated Net Income for 1 years, with the latest figure at $212958.0 in Q4 2025.
- For the quarter ending Q4 2025, Consolidated Net Income changed N/A year-over-year to $212958.0; the trailing twelve-month figure through Dec 2025 stood at $5.9 million (changed N/A YoY), and the FY2025 full-year result was $5.9 million, up 2222.83% from the prior year.
- Consolidated Net Income for Q4 2025 stood at $212958.0, down from $2.2 million in the prior quarter.
- The five-year high for Consolidated Net Income was $2.3 million in Q2 2025, with the low at $212958.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 3.87 Mn |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 2.22 Mn |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 2.52 Mn |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 2.89 Mn |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 1.49 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 2.75 Mn |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 2.17 Mn |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 2.95 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 1.70 Mn |
| 10 | Drugs Made In America Acquisition | - | - | - | 212,958.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 212,958.00 |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 1.25 Mn |